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Abstract 
A 30-year-old female patient presented to the gynecology clinic with a small (painless) 
swelling at the urethral orifice. She underwent surgical excision of the lesion. Pathological 
examination revealed non-Hodgkin’s lymphoma of diffuse large B-cell type and mucosa-
associated lymphoid tissue type, stage IE. The patient refused radiotherapy. Accordingly, we 
started CHOP-R chemotherapy. She received a total of 6 cycles of CHOP and 8 cycles of 
rituximab. Patient follow-up was done 3 months later through CT scan and cytoscopy 
confirming the complete remission. The patient has been disease-free for 4 years. We 
reviewed 26 cases of this rare entity reported previously. 
 
Introduction 
Lymphoma constitutes approximately 7% of all urogenital neoplasm [1]. The most 
frequent finding is of bladder involvement secondary to nodal disease [2]. Although 
cases of urethral lymphoma have been reported, the majority involve tumors arising in 
mucosa-associated lymphoid tissue (MALT) [3, 4]. Primary tumors arising from the 
urethra remain case reportable. Of the cases of primary urethral lymphoma that have  
Case Rep Oncol 2012;5:238–245 
DOI: 10.1159/000333357 
Published online: 
May 15, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
 
239 
been described, 19 cases have been reported in female patients and 7 cases in men, 1 of 
which was associated with HIV infection [1, 5–7]. Limited clinical experience has 
resulted in uncertainty concerning the most appropriate form of therapy for this 
malignancy. 
Case 
In February 2007, a 30-year-old woman presented to the gynecology clinic with a small painless 
mass at the urethral orifice. She underwent surgical excision of the lesion and histopathology revealed 
a mixture of acute and chronic inflammation consistent with urethral carbuncle. Two months later she 
presented with a hyperemic small swelling at the site of the excision. She underwent re-excision; and 
a mass from the urethral mucosa was biopsied. Pathologic examination of the specimen revealed a 
diffuse monotonous proliferation of malignant lymphoid cells of mostly large cell size; some of which 
are medium size and have a monocytoid appearance. The urethral mucosa above the infiltrate is 
focally infiltrated by malignant lymphoid cells (fig. 1, fig. 2). The deep component of the tumor 
infiltrates the glandular epithelium of the urethra (lymphoepithelial lesion); a feature strongly 
suggestive of MALT lymphoma (fig. 3). Immunohistochemistry for cytokeratin highlights these lesions 
(fig. 4, fig. 5). Immunocytochemistry studies demonstrated that the tumor cells have a strong positive 
reaction to CD45 (leukocytic common antigen, LCA) and CD20 (fig. 6). 
For staging workup she underwent chest, abdomen and pelvis CT which revealed no mediastinal 
lymphadenopathy, no lung focal lesion, a 3-mm cystic focus on the right lobe of the liver, normal 
spleen, pancreas and kidney, and no abdominal or pelvic lymphadenopathy. There is a slight apparent 
localized thickening of the bladder neck. MRI of the hepatic lesion revealed a simple benign cyst. 
Blood workup including LDH, ESR, β2 microglobulin, HIV, hepatitis and STD profile was done and all 
were normal. Bone marrow examination was negative. Upper gastrointestinal endoscopy did not 
reveal any MALT-associated lesions. Therefore, the final diagnosis was non-Hodgkin’s lymphoma of 
female urethra, diffuse large B-cell, possibly transformed from MALT lymphoma, stage IE according to 
Cotswolds modification of the Ann Arbor staging system. 
The patient was offered localized radiotherapy. She refused this modality after being counseled 
about the possible side effects including the high possibility of infertility. Accordingly, we offered her 
chemotherapy (R-CHOP regimen including, rituximab, cyclophosphamide, doxorubicin, vincristine, 
and prednisolone). The patient underwent staging reassessment with CT scan and cytoscopy after 4 
chemotherapy cycles. Multiple biopsies revealed a complete remission. A total of 6 cycles of CHOP and 
8 cycles of rituximab were completed. Patient follow-up was done 3 months later with CT scan and 
cytoscopy confirming the complete remission. The patient has been free of disease for 4 years. 
Discussion 
Caruncles are the most common lesions of the female urethra; they are inflammatory 
nodules that arise at the urethral meatus in postmenopausal women [8]. Urethral 
caruncles usually arise from the posterior lip of the urethral meatus. The lesion is 
considered to be neither neoplastic nor preneoplastic, but probably results from local 
trauma or inflammation. However, carcinoma (1.6%) and Bowen’s disease (0.8%) are 
extremely rare and have been noted in 2.4% of patients with a clinical diagnosis of 
urethral caruncle. Macroscopically, a caruncle is a nodular or pedunculated 
erythematous lesion that may bleed easily. 
Lymphoma of the female urethra, on the other hand, is an exceedingly rare 
condition. The literature describes only 27 cases (19 of them were female and 8 were 
male; table 1). All were non-Hodgkin’s lymphoma [9–13]. The age distribution ranged 
from 31 to 90 years with a mean of 67 years. The most common reported complaints  
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were polyp, dysuria, urethral mass, irregular vaginal bleeding, gross hematuria, pain, 
urinary retention, carbuncle, and genital itching [13–17]. 
Four cases have been reported as having a painless mass at the urethral meatus 
resembling a caruncle as in our own case [9, 10]. Two cases were treated with 
radiotherapy, one case was treated with excision, and the last was treated palliatively. 
Our case is the first urethral lymphoma case treated with chemotherapy (CHOP-R). 
Another male urethral case was treated with CHOP without rituximab. In that described 
case of primary lymphoma of a male urethra, the patient remained alive and in 
complete remission 2 years after surgical removal and 6 courses of CHOP 
chemotherapy. It has been reported that prognosis for short-term local control of the 
urethral tumor with chemotherapy is excellent; recent cases show a short-term control 
rate of 100% [18]. 
Conclusion 
There is no universally accepted treatment scheme for these tumors. Although, 
several authors have reported reasonable success using excision, radiotherapy, 
chemotherapy, or combinations. Although the number of cases reported was very small 
and the follow-up period was short in all cases, local therapy including excision or 
external beam radiation with/without chemotherapy showed a good outcome in 
patients with local or locally invasive tumor. However, patients with disseminated 
disease showed a poor prognosis regardless of the kind of initial treatment. 
Accordingly, in patients with unfavorable histology or disseminated disease, early 
intensive chemotherapy is recommended. Use of the chemotherapy regimen CHOP-R 
seems to be a reasonable treatment option. For patients without bulky disease, 6–8 
cycles of CHOP-R without radiotherapy have been shown to be an equally effective 
alternative as reported in our case [19]. Therefore, we recommend that any caruncle-
like lesion should be evaluated with a suspicion of a malignant tumor unless proved 
otherwise. 
 
 
  
Case Rep Oncol 2012;5:238–245 
DOI: 10.1159/000333357 
Published online: 
May 15, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
 
241 
Table 1. Summary of reported cases of primary urethral lymphoma 
                   
                    No.  First author  Year  Age 
years 
Sex  Chief complaint  Localization  Treatment  Outcome  Observation  
period 
                                       
01* Grabstald [16]   1966  Unknown  F  Unknown  Unknown  Radiation  NED  9 months 
02* Nabholtz [10]  1989  51  F  Urethral polyp   Localized urethral  Chemo + exci  NED  120 months 
03* Pak [11]  1980  83  F  Dysuria  Localized urethral  None  Dead  Unknown 
04* Simpson [12]  1990  76  F  Urethral mass  Localized urethral  Excision  NED  24 months 
05* Vapnek [15]  1992  31  F  Irregular vaginal bleeding  Localized urethral  Chemo + radi  NED  9 months 
06* Kakizaki [20]  1994  63  M  Urethral mass  Localized urethral  Chemo + exci  NED  36 months 
07* Ohsawa [21]  1994  78  F   Dysuria, polyuria  Localized urethral  Chemotherapy Unknown  Unknown 
08* Khatib [2]  1993  65  F   Irregular vaginal bleeding  Localized urethral  Excision  NED  24 months 
09* Atalay [19]  1998  76  F   Pain on urination, urinary tract 
tumor 
Localized urethral  None  Dead  Unknown 
10  Kurtman [22]  2001  32  M  Urinary retention  Localized urethral  Radiation  NED  15 months 
11  Masuda [3]  2002  56  M  Gross hematuria  Localized urethral  Radiation  NED  21 months 
12  Inuzuka [23]  2003  69  F  Dysuria, urinary tract tumors  Localized urethral  Exci + chemo  NED  6 months 
13  Ryu [24]  2003  25  M   Dysuria, tumor palpable lump  Localized urethral  Chemotherapy NED  67 months 
14  Chuang [25]  2005  50  F   Caruncle  Localized urethral  Radiation  NED  14.5 
months 
15  Richter [18]  2007  48  M   Dysuria, meat hematuria eye   Localized urethral  Exci + chemo  NED  3 months 
16* Melicow [9]  1972  76  F   Caruncle, hematuria  Local infiltration   TUR + radi  NED  12 months 
17* Touhami [13]  1987  63  F  Genital itching, dysuria  Local infiltration  Chemotherapy NED  48 months 
18* Selch [14]  1993  75  F   Irregular vaginal bleeding  Local infiltration  Radiation  NED  42 months 
19* Shimizu [26]  1997  82  F   Dysuria  Local infiltration  Chemo + radi  Dead  7 months 
20* Watson [27]  1949  62  F   Caruncle, spotting   Disseminated  Excision  Dead  5 months 
21* Allen [28]  1978  53  F   Caruncle  Disseminated  Palliative  Dead  2 months 
22* Chaitin [29]  1993  77  F   Genital mass, hematuria  Disseminated  Chemotherapy NED  9 months 
23* Lopez [6]  1993  57  M  Dysuria, hematuria   Disseminated  Chemotherapy Dead  3 months 
24* Rajan [30]  1995  57  M   Urinary retention, hematuria  Disseminated  Chemotherapy NED  6 months 
25  Dell'Atti [31]  2005  69  F   Dysuria, from thermal weight 
loss 
Progressive 
systemic 
Exci + chemo  Unknown  Unknown 
26  Muraoka [32]  2009  90  F  Dysuria  Localized urethral  Exci + radi  NED  14 months 
27  Al Zahrani  2011  30  F  Caruncle    Chemotherapy NED   
                                       
Exci = Excision; chemo = chemotherapy; TUR = transurethral resection; radi = radiation; NED = no evidence of disease. *Another hospital 
death. 
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Fig. 1. Diffuse monotonous proliferation of malignant lymphoid cells, the urethral mucosa above the 
infiltrate is focal (hematoxylin and eosin, ×100). 
 
 
 
Fig. 2. Diffuse proliferation of malignant ltmphoid cells (hematoxylin and eosin, ×400). 
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Fig. 3. Glandular epithelium of the urethra (lymphoepithelial lesion), a feature strongly suggestive of 
MALT lymphoma (hematoxylin and eosin, ×200). 
 
 
 
Fig. 4. Image highlights lymphoepithelial lesions; immunohistochemistry stain with cytokeratin 
(Dako; ×200). 
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Fig. 5. Image highlights lymphoepithelial lesion; immunohistochemistry stain with cytokeratin 
(Dako; ×400). 
 
 
 
Fig. 6. Image highlights lymphoid cells with positive reaction to CD20 (Dako; ×200). 
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